RB

Rashmi Bhan

Active Director Director DIN 01526330
DIN 01526330 First appointment Jan 2005 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2005
Shareholding value •••• Premium profile

About Rashmi Bhan

Data last updated:

Rashmi Bhan is a Director at Avalanche Pharmaceutical Private Limited (since 2005). The company operates in Pharma. Avalanche Pharmaceutical Private Limited reported revenue of ₹32.4 Lakh (FY 2016).

DIN 01526330
Primary Designation Director
Industry Pharma
First Appointment 28 Jan 2005
Oldest Company Age 21 yrs
Largest company Avalanche Pharmaceutical Private Limited · ₹32.4 Lakh (FY 2016)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director28 Jan 20052005₹32.4 Lakh (FY 2016)Active

Board colleagues of Rashmi Bhan

NameDINCompanyDesignation
Gautam Bhan01663450Avalanche Pharmaceutical Private LimitedDirector

Directorship timeline

Open interactive timeline →
Avalanche Pharmaceutical Private Limited
Premium access

Shareholding and investment profile for Rashmi Bhan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rashmi Bhan

Rashmi Bhan currently holds 1 directorship: Avalanche Pharmaceutical Private Limited (Director, since 28 Jan 2005, revenue ₹32.4 Lakh (FY 2016)).

Rashmi Bhan was first appointed on 28 Jan 2005 as Director at Avalanche Pharmaceutical Private Limited.

The current boards of Rashmi Bhan's companies include Gautam Bhan (Avalanche Pharmaceutical Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available